Global Ocular Inflammation Workshops 2019, Sapporo,Japan

Program

Program at a Glance, as of April 1, 2019
眼炎症教育プログラム 2Daysチケット参加登録のご案内
1. 11th International Workshop on Vogt-Koyanagi-Harada Disease and Sympathetic Ophthalmia
June 30 (Sunday), 9:30-13:00 (210min)
Chairs / Moderators: Kalpana Babu Murthy, MD (India)
Russell Read, MD, PhD (USA)
Hiroshi Goto, MD (Japan)
Speakers: Massimo Accorinti, MD, PhD (Italy)
Treatment of acute VKH in Italy
Jyotirmay Biswas, MD (India)
Treatment and visual outcome of Vogt-Koyanagi-Harada(VKH) from a tertiary centre of south India
Kessara Pathanapitoon, MD, PhD (Thailand)
Vogt-Koyanagi-Harada in Thailand
Soon-Phaik Chee, MD (Singapore)
Treatment of VKH in Singapore
Manabu Mochizuki, MD, PhD (Japan)
Treatment of VKH in Japan
Nisha R. Acharya, MD (USA)
Outcomes of VKH from the First-line Antimetabolites for Steroid-sparing Treatment Uveitis Trial
Panelists: Kenichi Namba, MD, PhD (Japan)
Hiroshi Keino, MD (Japan)
Moncef Khairallah, MD (Tunisia)
Shwu-Jiuan Sheu, MD (Taiwan)
SR. Rathinam, MD, PhD (India)
Thomas Albini, MD (USA)
Somsiri Sukhavatcharin, MD (Thailand)
Joyce Hisae Yamamoto, MD, PhD (Brazil)
Mudit Tyagi, MD (India)
2. 5th International Workshop on Ocular Behçet's Disease
June 29 (Saturday), 8:30-12:00 (210min)
Chairs / Moderators: Shigeaki Ohno, MD, PhD (Japan)
Moncef Khairallah, MD (Tunisia)
Massimo Accorinti, MD, PhD (Italy)
Speakers: Toshikatu Kaburaki, MD, PhD (Japan)
Global perspective /EULAR recommended treatment of Behcet's Disease and ocular Behçet'sDisease
Nobuyoshi Kitaichi, MD, PhD (Japan)
Treatment of ocular Behçet's disease and its duration in Japan
Hyeong-Gon Yu, MD, PhD (Korea)
Treatment of ocular BD and its duration in Korea
Masoud Soheilian, MD (Iran)
Treatment of Ocular Behcet's Disease and its Duration in Iran
Ilknur Tugal-Tutkun, MD (Turkey)
Treatment of ocular BD and its duration in Turkey
Moncef Khairallah, MD (Tunisia)
Treatment of ocular Behcet disease and its duration in North Africa and Middle East
Manfred Zierhurt, MD, PhD (Germany)
Evidence based treatment of ocular BD and its duration in Germany
Massimo Accorinti, MD, PhD (Italy)
Treatment of ocular BD and its duration in Italy
Panelists: Nobuhisa Mizuki, MD, PhD (Japan)
Hyeong-Gon Yu, MD, PhD (Korea)
Yih Shiou Hwang, MD, PhD (Taiwan)
Thanapong Somkijrungroj, MD (Thailand)
Masoud Soheilian, MD (Iran)
Ilknur Tugal-Tutkun, MD (Turkey)
Hassan Al-Dhibi, MD (Saudi Arabia)
Manfred Zierhurt, MD, PhD (Germany)
3. 7th International Workshop on Ocular Sarcoidosis
June 29 (Saturday), 13:10-16:40 (210min)
Chairs / Moderators: Manabu Mochizuki, MD, PhD (Japan)
Justine R. Smith, FRANZCO, PhD (Australia)
Nisha R. Acharya, MD (USA)
Speakers: Daniel Vitor Vasconcelos-Santos, MD, PhD (Brazil)
Overview of ocular sarcoidosis
Claude L. Cowan Jr., MD, MPH (USA)
Global perspectives on the management of ocular sarcoidosis
Koh-Hei Sonoda, MD, PhD (Japan)
Controversies in the management of ocular sarcoidosis: systemic vs. local; medical vs. surgical
Careen Yen Lowder, MD. PhD (USA)
Management of Sarcoidosis in North and South America
Peter McCluskey, MD (Australia)   
Management of ocular sarcoidosis in Australasia
Mami Ishihara, MD, PhD (Japan)
Management of ocular sarcoidosis in Japan
Manfred Zierhurt, MD, PhD (Germany)
Management of ocular sarcoidosis in Europe and challenges in its management
Carl P. Herbort Jr., MD, PD (Switzerland)
Precise evaluation of posterior ocular sarcoidosis for better disease appraisal and management.
Panelists: Hiroshi Takase, MD, PhD (Japan)
Nattaporn Tesavibul, MD (Thailand)
Kalpana Babu Murthy, MD (India)
Peter McCluskey, MD (Australia)
Ilknur Tugal-Tutkun, MD (Turkey)
Bahram Bodaghi, MD, PhD (France)
Moncef Khairallah, MD (Tunisia)
Jennifer Thorne, MD, PhD (USA)
Joyce Hisae Yamamoto, MD, PhD (Brazil)
4. 6th International Workshop on Ocular Tuberculosis
June 28 (Friday), 13:40-17:10 (210min)
Chairs / Moderators: Soumyava Basu (India)
Daniel Vitor Vasconcelos-Santos, MD, PhD (Brazil)
Annabelle A. Okada, MD, PhD (Japan)
Speakers: Annabelle A. Okada, MD, PhD (Japan)
WHO recommended treatment and treatment of extrapulmonary tuberculosis
Parthopratim Dutta Majumder, MD (India)
Treatment of intraocular tuberculosis and its duration in India
May Zun Aung Win, MD (Myanmar)
Treatment of Intraocular tuberculosis and its duration in Myanmar
Derrick P Smit, MD, PhD, FCOphth(SA), MMed (South Africa)
Diagnosis and treatment of intraocular tubreculosis in South Africa
Daniel Vitor Vasconcelos-Santos, MD, PhD (Brazil)
Treatment of Intraocular tuberculosis and its duration in South America
John Gonzales, MD (USA)
Intraocular Tuberculosis - a North American Perspective
Edoardo Baglivo, MD (Switzerland)
Treatment of Intraocular tuberculosis and its duration in Europe
Panelists: Narsing Rao, MD (USA)
John Gonzales, MD (USA)
Wesley Ribeiro Campos, PhD (Brazil)
Carlos Pavesio, MD (United Kingdom)
Padmamalini Mahendradas, MBBD DO, DNB (India)
Shelina Oli Mohamed, MD, Fellowship in Uvetis (Malaysia)
Hassan Al-Dhibi, MD (Saudi Arabia)
Rina La Distia Nora, MD (Indonesia)
Yong Tao, MD (China)
Jessica Marie Abano, MD (Philippines)
Somsiri Sukhavatcharin (Thailand)
5-1. 2nd International Workshop on Diabetic Retinopathy and Age-Related Macular Degeneration-DM
June 28 (Friday), 9:00-10:40 (100min)
Chairs / Moderators: Susumu Ishida, MD, PhD (Japan)
Shwu-Jiuan Sheu, MD (Taiwan)
Quan Dong Nguyen, MD, MSc, FAAO (USA)
Speakers: Chang-Hao Yang, MD, PhD (Taiwan)
Inflammatory mediators in the pathogenesis of diabetic macular edema
Quan Dong Nguyen, MD, MSc, FAAO (USA)
The Role of Interleukin-6 in Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration
Marten Brelen, MD PhD (Hong Kong)
Pharmacognetics of Angiopoietin2 for the Treatment of Diabetic Macular Edema
Masahiko Shimura, MD, PhD (Japan)
Response to anti-VEGF drugs for diabetic macular edema
Shih-Jen Chen, MD, PhD (Taiwan)
Diabetic macular ischemia-the unmet need
Chui Ming Gemmy Cheung, MD (Singapore)
Diabetic macular ischemia-new imaging insights and functional correlates
Seung-Young Yu, MD, PhD (Korea)
Before microanerysm
Krishna Ramachandra Murthy, MD, PhD (India)
Diabetic Retinopathy, The Indian Scenario
5-2. 2nd International Workshop on Diabetic Retinopathy and Age-Related Macular Degeneration-AMD
June 28 (Friday), 10:50-12:30 (100min)
Chairs / Moderators: Susumu Ishida, MD, PhD (Japan)
Timothy Lai, MD (Hong Kong)
Won Ki Lee, MD, PhD (Korea)
Speakers: Won Ki Lee, MD, PhD (Korea)
Thin Pachychoroid
Yoko Ozawa, MD, PhD (Japan)
Dynamic changes of choroidal conditions in age-related macular degeneration
Hyung Chan Kim, MD, PhD (Korea)
Automated Segmentation of Lesions in AMD
Timothy Lai, MD (Hong Kong)
New therapeutic developments for neovascular AMD: non-VEGF pathways
Adrian Koh, MD, FRCS, FRCOphth (Singapore)
Emerging Therapies for Neovascular AMD: Anti VEGF Pathways
Lee-Jen Chen, MD (Taiwan)
EVEREST 2 vs. PLANET
Paisan Ruamviboonsuk, MD (Thailand)
Applying Deep Learning for Diabetic Retinopathy Screening in Thailand
Rajendra S. Apte, MD, PhD (USA)
Molecular Pathogenesis and Therapeutic Challenges in AMD
6. 8th Asia Pacific Intraocular Inflammation Study Group Meeting
June 28 (Friday), 17:20-18:20 (60min)
Chairs / Moderators: Soon-Phaik Chee, MD (Singapore)
Narsing Rao, MD (USA)
Manfred Zierhut, MD, PhD (Germany)
Speakers: Pia Regina E. Galvante, MD (Philippines)
The Ring: Bilateral ring fibrosis and retinal detachment in a 5-year old boy
Diem Quang Hong Vo (Vietnam)
Toxoplasmic Chorioretinitis in HIV-AIDS Patients
Fatma Asyariah, MBBS, MD, SpM (K) (Indonesia)
Challenging cases on Ocular Tuberculosis
Shelina Oli Mohamed, MD (Malaysia)
Please save my only eye
May Zun Aung Win, MD (Myanmar)
Infectious Posterior Uveitis
Invited Talk: Peter McCluskey, MD (Australia)
Paediatric uveitis - Pearls for diagnosis and management
Panelists: Peter McCluskey, MD (Australia)
Hiroshi Goto, MD (Japan)
Justine R. Smith, FRANZCO, PhD (Australia)

June 29 (Saturday), 16:50-17:50 (60min)
Chairs / Moderators: Hiroshi Takase, MD, PhD (Japan)
Bahram Bodaghi, MD, PhD (France)
Carl P. Herbort Jr., MD, PD (Switzerland)
Speakers: Mafruha Afrin, FRCS (Glasgow) (Bangladesh)
Perplexity of a Challenging Uveitis Case
Samanthila Waduthantri, MD, (Singapore)
A challenging case
Yutaka Kaneko, MD (Japan)
The Utility of Liquid-based Cytology in Diagnosis of Intraocular Lymphoma and Sarcoidosis
Chang-Ping Lin, MD (Taiwan)
Long term result of treating CMV iritis------Seeing the whole picture
Shishir Narain, FRCOphth, FRCSEd, FMRF (India)
Diagnostic dilemma and challenges of VKH versus Multiple -leak CSR
Invited Talk: Hyeong Gon Yu, MD, PhD (Korea)
How to suspect and diagnose the Masquerade Syndromes
Panelists: Hyeong Gon Yu, MD, PhD (Korea)
Moncef Khairallah, MD (Tunisia)
Joyce Hisae Yamamoto, MD, PhD (Brazil)

7. Luncheon Seminar
June 28 (Friday), 12:40-13:30 (50min)
1. Update on Treatments for Diabetic Macular Edema
Chair: Masahiko Shimura, MD, PhD (Japan)
Speakers: Miho Nozaki, MD, PhD (Japan)
Update on medical treatments for diabetic macular edema
Yuki Morizane, MD, PhD (Japan)
Update on surgical treatments for diabetic macular edema
 
Sponsored by Novartis Pharma K.K.
June 28 (Friday), 12:40-13:30 (50min)
2. The concept of therapeutic window of opportunity in initial-onset VKH uveitis and the treatment strategies resulting from it
Chair: Shigeaki Ohno MD, PhD (Japan)
Speaker: Carl P. Herbort Jr., MD, PD (Switzerland)
Sponsored by Eisai Co., Ltd. and AbbVie GK
June 29 (Saturday), 12:10-13:00 (50min)
3. Views and Reviews of AMD
Chair: Yoko Ozawa, MD, PhD (Japan)
Speakers: Kenji Yamashiro, MD, PhD (Japan)
Opposite effects of CFH in age-related macular degeneration and pachychoroid disease
Rajendra S. Apte, MD, PhD (USA)
An Eye on VEGF in Discovery and Development
Sponsored by Bayer Yakuhin, Ltd. and Santen Pharmaceutical Co., Ltd.
June 29 (Saturday), 12:10-13:00 (50min)
4. Infliximab for the treatment of Behçet's disease
Chair: Hiroshi Goto, MD, PhD (Japan)
Speaker: Shigeaki Ohno, MD, PhD (Japan)
Sponsored by Mitsubishi Tanabe Pharma Corporation
8. Morning Seminar
June 30 (Sunday), 8:30-9:20 (50min)
1. Combat inflammation in the choroid and the retina! Treatment strategy for VKH and DME
Chair: Susumu Ishida, MD, PhD (Japan)
Speakers: Nobuyuki Ohguro, MD (Japan)
Management of Vogt-Koyanagi-Harada Disease
Yuichiro Ogura, MD, PhD (Japan)
Paradigm Shift in the Management of Diabetic Macular Edema
 
Sponsored by WAKAMOTO PHARMACEUTICAL Co., Ltd.
June 30 (Sunday), 8:30-9:20 (50min)
2. Thinking about inflammatory eye diseases (Japanese Program)
炎症性眼疾患を考える
Chair: Toshinori Murata, MD, PhD (Japan)
Speakers: Kiyoshi Suzuma, MD, PhD (Japan)
Mechanisms of Retinal Vascular Diseases
網膜血管障害のメカニズム
Kenichi Namba, MD, PhD (Japan)
Long-term efficacy and safety of tacrolimus ophthalmic solusion for vernal keratoconjunctivitis
春季カタルにおけるタクロリムス点眼薬の有効性と安全性
Sponsored by Senju Pharmaceutical Co., Ltd.